[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f3kko4cihp4z5y":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"name":15,"company":12,"products":16,"catalysts":44},"RIGEL PHARMS",[17,25,31,38],{"tradeName":18,"slug":19,"ingredient":20,"applNo":21,"loe":22,"basis":23,"carveOutPossible":13,"strengths":24},"TAVALISSE","tavalisse","FOSTAMATINIB DISODIUM","209299","2032-07-27","patent",2,{"tradeName":26,"slug":27,"ingredient":28,"applNo":29,"loe":30,"basis":23,"carveOutPossible":13,"strengths":24},"VEPPANU","veppanu","VEPDEGESTRANT","219835","2038-01-30",{"tradeName":32,"slug":33,"ingredient":34,"applNo":35,"loe":36,"basis":23,"carveOutPossible":13,"strengths":37},"REZLIDHIA","rezlidhia","OLUTASIDENIB","215814","2039-11-12",1,{"tradeName":39,"slug":40,"ingredient":41,"applNo":42,"loe":43,"basis":23,"carveOutPossible":13,"strengths":37},"GAVRETO","gavreto","PRALSETINIB","213721","2043-04-19",[45,54],{"id":46,"type":47,"eventDate":48,"detectedAt":49,"tradeName":18,"slug":19,"payload":50},1854,"FIRST_GENERIC_APPROVED","2026-06-17","2026-10-25T00:12:15.155Z",{"note":51,"andaNo":52,"sponsor":53,"ingredient":20},"first approved ANDA seen for this RLD in Drugs@FDA; verify against FDA first-generics list","217329","ANNORA PHARMA",{"id":55,"type":56,"eventDate":48,"detectedAt":57,"tradeName":18,"slug":19,"payload":58},1853,"ANDA_APPROVED","2026-10-25T00:12:15.000Z",{"route":59,"andaNo":52,"sponsor":53,"dosageForm":60,"ingredient":20},"ORAL","TABLET"]